Login
Home
Charts
Search
Watchlist
Products

Viyash Scientific Ltd

VIYASH·NSE
251.50-0.06%Tue, 22 Sept '26 15:56

Viyash Scientific Ltd

VIYASH
NSE
251.50
-0.06%
|Tue, 22 Sept '26 15:56
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
11,153Cr
Close
Close Price
252.55
Industry
Industry
Pharma - Animal
PE
Price To Earnings
51.75
PS
Price To Sales
3.12
Revenue
Revenue
3,575Cr
Rev Gr TTM
Revenue Growth TTM
53.04%
PAT Gr TTM
PAT Growth TTM
179.65%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
346329361390369774402792850858920946
Growth YoY
Revenue Growth YoY%
2.5-12.2-1.517.16.6135.011.2102.9130.710.9129.019.5
Expenses
ExpensesCr
331307329348330674355673677683736768
Operating Profit
Operating ProfitCr
152232423910046119173176184178
OPM
OPM%
4.46.88.910.810.612.911.515.020.420.520.018.9
Other Income
Other IncomeCr
107-1304166-27168
Interest Expense
Interest ExpenseCr
131312161421152018171513
Depreciation
DepreciationCr
151516161758165659596062
PBT
PBTCr
-31312824164810273125112
Tax
TaxCr
4-9132-1761129255933
PAT
PATCr
-71119642103773496679
Growth YoY
PAT Growth YoY%
-55.0209.2101.4126.1192.2292.7717.3306.71,049.815.7539.5115.2
NPM
NPM%
-2.03.20.32.31.75.42.64.78.65.77.28.4
EPS
EPS
-0.30.30.00.30.11.00.40.61.30.91.21.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
346329361390369774402792850858920946
Growth YoY
Revenue Growth YoY%
2.5-12.2-1.517.16.6135.011.2102.9130.710.9129.019.5
Expenses
ExpensesCr
331307329348330674355673677683736768
Operating Profit
Operating ProfitCr
152232423910046119173176184178
OPM
OPM%
4.46.88.910.810.612.911.515.020.420.520.018.9
Other Income
Other IncomeCr
107-1304166-27168
Interest Expense
Interest ExpenseCr
131312161421152018171513
Depreciation
DepreciationCr
151516161758165659596062
PBT
PBTCr
-31312824164810273125112
Tax
TaxCr
4-9132-1761129255933
PAT
PATCr
-71119642103773496679
Growth YoY
PAT Growth YoY%
-55.0209.2101.4126.1192.2292.7717.3306.71,049.815.7539.5115.2
NPM
NPM%
-2.03.20.32.31.75.42.64.78.65.77.28.4
EPS
EPS
-0.30.30.00.30.11.00.40.61.30.91.21.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6066848481,0391,1791,3621,4131,4211,3703,0073,4203,575
Growth
Revenue Growth%
36.812.824.022.613.515.53.80.6-3.6119.513.853.0
Expenses
ExpensesCr
5516417659141,0091,1501,3031,4091,3082,6202,7682,864
Operating Profit
Operating ProfitCr
5543831251702121091261387653711
OPM
OPM%
9.16.39.812.014.415.67.70.84.512.919.119.9
Other Income
Other IncomeCr
131115910011-58-6-49-13
Interest Expense
Interest ExpenseCr
382833333624163648866961
Depreciation
DepreciationCr
464041425151525662239234240
PBT
PBTCr
-15-1424599413753-138-5513349413
Tax
TaxCr
3-113212328-16-25-3124146
PAT
PATCr
-18-1410578210445-122-3016225267
Growth
PAT Growth%
73.122.8173.5458.344.327.3-57.1-372.575.7153.21,324.8179.7
NPM
NPM%
-3.0-2.01.25.57.07.73.2-8.6-2.20.56.67.5
EPS
EPS
-0.8-0.5-0.12.02.93.91.6-4.9-1.40.54.14.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6066848481,0391,1791,3621,4131,4211,3703,0073,4203,575
Growth
Revenue Growth%
36.812.824.022.613.515.53.80.6-3.6119.513.853.0
Expenses
ExpensesCr
5516417659141,0091,1501,3031,4091,3082,6202,7682,864
Operating Profit
Operating ProfitCr
5543831251702121091261387653711
OPM
OPM%
9.16.39.812.014.415.67.70.84.512.919.119.9
Other Income
Other IncomeCr
131115910011-58-6-49-13
Interest Expense
Interest ExpenseCr
382833333624163648866961
Depreciation
DepreciationCr
464041425151525662239234240
PBT
PBTCr
-15-1424599413753-138-5513349413
Tax
TaxCr
3-113212328-16-25-3124146
PAT
PATCr
-18-1410578210445-122-3016225267
Growth
PAT Growth%
73.122.8173.5458.344.327.3-57.1-372.575.7153.21,324.8179.7
NPM
NPM%
-3.0-2.01.25.57.07.73.2-8.6-2.20.56.67.5
EPS
EPS
-0.8-0.5-0.12.02.93.91.6-4.9-1.40.54.14.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4849494950505050505087
Reserves
ReservesCr
8859285996576376786336496072,3822,731
Current Liabilities
Current LiabilitiesCr
2906644314344954605125596271,015946
Non Current Liabilities
Non Current LiabilitiesCr
290247227207236156199221200552568
Total Liabilities
Total LiabilitiesCr
1,5281,9051,3431,3881,4631,3931,4511,5291,5404,1324,628
Current Assets
Current AssetsCr
4917285386007047147837808111,7832,255
Non Current Assets
Non Current AssetsCr
1,0381,1778057887596796687497292,3492,374
Total Assets
Total AssetsCr
1,5281,9051,3431,3881,4631,3931,4511,5291,5404,1324,628
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4849494950505050505087
Reserves
ReservesCr
8859285996576376786336496072,3822,731
Current Liabilities
Current LiabilitiesCr
2906644314344954605125596271,015946
Non Current Liabilities
Non Current LiabilitiesCr
290247227207236156199221200552568
Total Liabilities
Total LiabilitiesCr
1,5281,9051,3431,3881,4631,3931,4511,5291,5404,1324,628
Current Assets
Current AssetsCr
4917285386007047147837808111,7832,255
Non Current Assets
Non Current AssetsCr
1,0381,1778057887596796687497292,3492,374
Total Assets
Total AssetsCr
1,5281,9051,3431,3881,4631,3931,4511,5291,5404,1324,628

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-745116115115311731345323
Investing Cash Flow
Investing Cash FlowCr
-316-1167-68-7210-96-65-6-447-84
Financing Cash Flow
Financing Cash FlowCr
309147-57-20-43-1396732-187-123
Net Cash Flow
Net Cash FlowCr
-724-5280-142-1623-15115
Free Cash Flow
Free Cash FlowCr
2-447937570-1-5819258225
CFO To PAT
CFO To PAT%
0.351.9444.0204.0140.6109.968.3-13.8-103.32,186.8143.7
CFO To EBITDA
CFO To EBITDA%
-0.1-16.754.592.967.754.128.0140.649.889.149.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-745116115115311731345323
Investing Cash Flow
Investing Cash FlowCr
-316-1167-68-7210-96-65-6-447-84
Financing Cash Flow
Financing Cash FlowCr
309147-57-20-43-1396732-187-123
Net Cash Flow
Net Cash FlowCr
-724-5280-142-1623-15115
Free Cash Flow
Free Cash FlowCr
2-447937570-1-5819258225
CFO To PAT
CFO To PAT%
0.351.9444.0204.0140.6109.968.3-13.8-103.32,186.8143.7
CFO To EBITDA
CFO To EBITDA%
-0.1-16.754.592.967.754.128.0140.649.889.149.5

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,4883,1411,8871,7741,9305,9833,3231,8112,8763,2748,00311,153
Price To Earnings
Price To Earnings
4.536.527.662.781.1140.745.151.8
Price To Sales
Price To Sales
5.84.62.21.71.64.42.41.32.11.12.33.1
Price To Book
Price To Book
3.73.22.92.52.88.24.92.64.41.42.84.0
EV To EBITDA
EV To EBITDA
67.680.425.315.812.629.333.2185.153.69.812.615.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.037.136.937.740.140.435.532.636.841.545.345.3
OPM
OPM%
9.16.39.812.014.415.67.70.84.512.919.119.9
NPM
NPM%
-3.0-2.01.25.57.07.73.2-8.6-2.20.56.67.5
ROCE
ROCE%
1.91.06.39.313.216.06.6-8.9-0.63.212.612.6
ROE
ROE%
-1.9-1.41.68.111.914.36.5-17.5-4.50.78.08.0
ROA
ROA%
-1.2-0.70.84.15.67.53.1-8.0-1.90.44.84.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,4883,1411,8871,7741,9305,9833,3231,8112,8763,2748,00311,153
Price To Earnings
Price To Earnings
4.536.527.662.781.1140.745.151.8
Price To Sales
Price To Sales
5.84.62.21.71.64.42.41.32.11.12.33.1
Price To Book
Price To Book
3.73.22.92.52.88.24.92.64.41.42.84.0
EV To EBITDA
EV To EBITDA
67.680.425.315.812.629.333.2185.153.69.812.615.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.037.136.937.740.140.435.532.636.841.545.345.3
OPM
OPM%
9.16.39.812.014.415.67.70.84.512.919.119.9
NPM
NPM%
-3.0-2.01.25.57.07.73.2-8.6-2.20.56.67.5
ROCE
ROCE%
1.91.06.39.313.216.06.6-8.9-0.63.212.612.6
ROE
ROE%
-1.9-1.41.68.111.914.36.5-17.5-4.50.78.08.0
ROA
ROA%
-1.2-0.70.84.15.67.53.1-8.0-1.90.44.84.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Viyash Scientific Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/a8x5mgk2vtjrptvnra9mo20r.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/zr1swe273wrv562h3ie5l17x.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/vyej2datd5zkbi3clhf60k95.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/j1x2xgsu2yxvcpbzratm7phm.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/k6gedvjoad814tql4ac1xh4b.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/ogac024arwpfudg4gecor2qp.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/iwcz7n96j3z448ow5albe8ug.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/xhx6q1umasiieyux5srgq8yj.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/c2aa2koswvs7l5ya6oas9x5k.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/m592jisv78e5cuw5u7a74vz4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/7hzytp7a4nl4ir16d4wc6c71.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/yc5bm1vqesq3jtrucesfwof9.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/g7qmlji2euyczpexp0jv4an5.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/oc8j0r3t083bwk87gr3m1z16.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/zpmflw84301yyts48pjjwhkn.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/6eoq2849fp3osi2qq7bygh5a.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/vmwa7n2jtvn8ot6qzjba9mln.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/8x40qcqj07i39e0chi6c4d7y.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/dit80jfgs09q9neqy7m9l25h.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/hognvbvdjfk7nl7s3jew7fbn.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/7pkuxnbhrtelf0oxjc3uf02e.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/xdtjdwihm4f7y31fwa5z20ex.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/lmd45aelhekw37q5am9pnled.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/aehjny974h3gblr1v0uhv4kh.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/uwldsmn0h2pxn0ioekpdtda4.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/aeu2nnlg30yh0fbl76hfxung.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/5g8atwcngopwpi3nptpkqg7z.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/ulrq6gz6chn2air0s7eesi71.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/i8l165icd548hdt1d0uc9ttk.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/6f4i05w0xqxy1gc8qc00w7rl.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/itlg4x5iqkl4glceb7pvupfw.pdf

Concall Transcript Summaries — Viyash Scientific Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202606/a8x5mgk2vtjrptvnra9mo20r.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202603/zr1swe273wrv562h3ie5l17x.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202512/vyej2datd5zkbi3clhf60k95.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202509/j1x2xgsu2yxvcpbzratm7phm.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202506/k6gedvjoad814tql4ac1xh4b.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202503/ogac024arwpfudg4gecor2qp.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202412/iwcz7n96j3z448ow5albe8ug.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AVIYASH/transcript-notes/202409/xhx6q1umasiieyux5srgq8yj.pdf